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    Phosphatic stones， particularly struvite stones， are thought to develop in the urinary tract infected
by urea sp｝itting microorganism．
    The hydroxamic acid is known to be a specific and effective inhibitor of bacterial urease．
    Urinary excretion of several hydroxamic acid derivertives was investigated after oral administra－
tion to the experimental．rats．
   Approximately 300／． of acetohydroxamic acid was excreted in urine unchanged for 24 hours after
administration． 24 hour excretions of other hydroxamic acids were as follows： serine－90／，， histidine－
S．40／．， nicotino－1．00／，， caplyro－1．00／．， glycine－O．90／， and benzo－O．60／．．
    Effective index （＝recovery O／， tlso． （yM）） of acetohydroxamic acid was 3：05 and that of nico－
tinohydroxamic acid was O．50．
   Teratogenic action of acetohydroxamic acid in rats had been reported， but that of nicotino－
hydroxamic acid was not reported． yet．
   Administration of nicotinohydrpxamic acid to rats with urinary tract infection caused by Proteus
mirabilis sign’ificantly prevented alkalinization of urine as well as bladder stone formatiQn． The extent
of pyelonf， phritis and azotemia噸9 much less tha皿that in the untrcated control animals．
   The hydroxamic acid derivatives more potent than nicotinohydroxamic acid will become useful
















































Fig． 1． Bladder stone































































Table 2．Effect of nicotinohydroxamic acid
on bladder stone．











Number Urine Viable Stone mg Kidney
ot rats pH ml cell （composition）
Table 1． Urinary excretion of hydroxamic
     acids in rats．
Hydroxamic ecid lso Dese Number Recovery Ole Effective
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32．4 42．S Renal obscess
32．5 43．5 Pyelonephritis
22．0 t44．1 Pyelonephritls
28．2 43．5 Renal ebscess
47．9 95．5 Pyelonephritis
52，7 47．i Pyelonephritis
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freo暫ed
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Fig． 4． Mean BUN and renal infection
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